247 related articles for article (PubMed ID: 30804005)
21. Prognostic value of intra-tumoral CD8
Sideras K; Galjart B; Vasaturo A; Pedroza-Gonzalez A; Biermann K; Mancham S; Nigg AL; Hansen BE; Stoop HA; Zhou G; Verhoef C; Sleijfer S; Sprengers D; Kwekkeboom J; Bruno MJ
J Surg Oncol; 2018 Jul; 118(1):68-76. PubMed ID: 29878369
[TBL] [Abstract][Full Text] [Related]
22. C-reactive protein/albumin ratio and Glasgow prognostic score are associated with prognosis and infiltration of Foxp3+ or CD3+ lymphocytes in colorectal liver metastasis.
Kanno H; Hisaka T; Akiba J; Hashimoto K; Fujita F; Akagi Y
BMC Cancer; 2022 Aug; 22(1):839. PubMed ID: 35915403
[TBL] [Abstract][Full Text] [Related]
23. The Impact of Immune Interaction on the Metastatic Infiltration of Colorectal Carcinoma to Lymph Nodes.
Vycital O; Dubova M; Palek R; Hosek P; Branzovsky J; Treska V; Daum O; Liska V
Anticancer Res; 2018 Jul; 38(7):4159-4167. PubMed ID: 29970545
[TBL] [Abstract][Full Text] [Related]
24. Infiltration of CD3⁺ and CD68⁺ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors.
Sjödahl G; Lövgren K; Lauss M; Chebil G; Patschan O; Gudjonsson S; Månsson W; Fernö M; Leandersson K; Lindgren D; Liedberg F; Höglund M
Urol Oncol; 2014 Aug; 32(6):791-7. PubMed ID: 24794251
[TBL] [Abstract][Full Text] [Related]
25. The Prognostic Implications of Tumor Infiltrating Lymphocytes in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Idos GE; Kwok J; Bonthala N; Kysh L; Gruber SB; Qu C
Sci Rep; 2020 Feb; 10(1):3360. PubMed ID: 32099066
[TBL] [Abstract][Full Text] [Related]
26. Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma.
Sinicrope FA; Rego RL; Ansell SM; Knutson KL; Foster NR; Sargent DJ
Gastroenterology; 2009 Oct; 137(4):1270-9. PubMed ID: 19577568
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy.
Tsiatas M; Kalogeras KT; Manousou K; Wirtz RM; Gogas H; Veltrup E; Zagouri F; Lazaridis G; Koutras A; Christodoulou C; Pentheroudakis G; Petraki C; Bafaloukos D; Pectasides D; Kosmidis P; Samantas E; Karanikiotis C; Papakostas P; Dimopoulos MA; Fountzilas G
Cancer Med; 2018 Oct; 7(10):5066-5082. PubMed ID: 30240146
[TBL] [Abstract][Full Text] [Related]
28. Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer.
Michael-Robinson JM; Pandeya N; Walsh MD; Biemer-Huttmann AE; Eri RD; Buttenshaw RL; Lincoln D; Clouston AD; Jass JR; Radford-Smith GL
J Pathol; 2006 Feb; 208(3):381-7. PubMed ID: 16315333
[TBL] [Abstract][Full Text] [Related]
29. The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer.
Li J; Wang J; Chen R; Bai Y; Lu X
Oncotarget; 2017 Feb; 8(9):15621-15631. PubMed ID: 28152503
[TBL] [Abstract][Full Text] [Related]
30. Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis.
Frei AL; McGuigan A; Sinha RRAK; Jabbar F; Gneo L; Tomasevic T; Harkin A; Iveson T; Saunders MP; Oien KA; Maka N; Pezzella F; Campo L; Browne M; Glaire M; Kildal W; Danielsen HE; Hay J; Edwards J; Sansom O; Kelly C; Tomlinson I; Kerr R; Kerr D; Domingo E; ; Church DN; Koelzer VH
Lancet Oncol; 2024 Feb; 25(2):198-211. PubMed ID: 38301689
[TBL] [Abstract][Full Text] [Related]
31. Clinical impact of heterogeneously distributed tumor-infiltrating lymphocytes on the prognosis of colorectal cancer.
Liu L; Long M; Su S; Wang L; Liu J
PeerJ; 2024; 12():e16747. PubMed ID: 38223758
[TBL] [Abstract][Full Text] [Related]
32. Inclusion of BLIMP-1
Ward-Hartstonge KA; McCall JL; McCulloch TR; Kamps AK; Girardin A; Cretney E; Munro FM; Kemp RA
Cancer Immunol Immunother; 2017 Apr; 66(4):515-522. PubMed ID: 28116480
[TBL] [Abstract][Full Text] [Related]
33. Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma.
Weiss SA; Han SW; Lui K; Tchack J; Shapiro R; Berman R; Zhong J; Krogsgaard M; Osman I; Darvishian F
Hum Pathol; 2016 Nov; 57():116-125. PubMed ID: 27473267
[TBL] [Abstract][Full Text] [Related]
34. Marine ω-3 Polyunsaturated Fatty Acid Intake and Risk of Colorectal Cancer Characterized by Tumor-Infiltrating T Cells.
Song M; Nishihara R; Cao Y; Chun E; Qian ZR; Mima K; Inamura K; Masugi Y; Nowak JA; Nosho K; Wu K; Wang M; Giovannucci E; Garrett WS; Fuchs CS; Ogino S; Chan AT
JAMA Oncol; 2016 Sep; 2(9):1197-206. PubMed ID: 27148825
[TBL] [Abstract][Full Text] [Related]
35. Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?
Koletsa T; Kotoula V; Koliou GA; Manousou K; Chrisafi S; Zagouri F; Sotiropoulou M; Pentheroudakis G; Papoudou-Bai A; Christodoulou C; Xepapadakis G; Zografos G; Petraki K; Pazarli E; Koutras A; Kourea HP; Bafaloukos D; Chatzopoulos K; Iliadis A; Markopoulos C; Venizelos V; Arnogiannaki N; Kalogeras KT; Kostopoulos I; Gogas H; Fountzilas G
Cancer Immunol Immunother; 2020 Aug; 69(8):1549-1564. PubMed ID: 32303794
[TBL] [Abstract][Full Text] [Related]
36. Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma.
Han S; Zhang C; Li Q; Dong J; Liu Y; Huang Y; Jiang T; Wu A
Br J Cancer; 2014 May; 110(10):2560-8. PubMed ID: 24691423
[TBL] [Abstract][Full Text] [Related]
37. CD3 high and FoxP3 - tumor-infiltrating lymphocytes in the invasive margin as a favorable prognostic marker in patients with invasive urothelial carcinoma of the bladder.
Sun ZJ; Zhao JW; Zhao M; Chen Y; Zhang X; Li HC; Wu GQ; Zhang DH
Anticancer Drugs; 2023 Aug; 34(7):844-851. PubMed ID: 36563023
[TBL] [Abstract][Full Text] [Related]
38. Scoring System for Tumor-Infiltrating Lymphocytes and Its Prognostic Value for Gastric Cancer.
Zhang D; He W; Wu C; Tan Y; He Y; Xu B; Chen L; Li Q; Jiang J
Front Immunol; 2019; 10():71. PubMed ID: 30761139
[TBL] [Abstract][Full Text] [Related]
39. The clinical utility of the local inflammatory response in colorectal cancer.
Richards CH; Roxburgh CS; Powell AG; Foulis AK; Horgan PG; McMillan DC
Eur J Cancer; 2014 Jan; 50(2):309-19. PubMed ID: 24103145
[TBL] [Abstract][Full Text] [Related]
40. Linear quantification of lymphoid infiltration of the tumor margin: a reproducible method, developed with colorectal cancer tissues, for assessing a highly variable prognostic factor.
Allard MA; Bachet JB; Beauchet A; Julie C; Malafosse R; Penna C; Nordlinger B; Emile JF
Diagn Pathol; 2012 Nov; 7():156. PubMed ID: 23148481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
